BioLargo, Inc.

BioLargo, Inc. (OTCQB:BLGO) invents, develops, and commercializes innovative platform technologies to solve challenging environmental problems like PFAS contamination, advanced water and wastewater treatment, industrial odor and VOC control, air quality control, and infection control.

Tuesday, 7 July 2009

EPA RED for Iodine and Iodophors - Published June 2009

The Federal Registry Summary of the RED for Iodine and Iodophors can be read here.

Details Here


Posted by BioLargo at 05:58 No comments:
Newer Posts Older Posts Home
Subscribe to: Posts (Atom)

Twitter Link

Twitter Link
@BioLargo

Get in touch

Get in touch
Want to get in touch about a business opportunity or idea? Click the light bulb and get in touch with us!

Important BioLargo® Posts

  • BioLargo 2020 Annual Report Highlights
  • BioLargo and Garratt-Callahan Team Up for Product Development Project
  • BioLargo Generates Record Revenue in 2020
  • BioLargo Manufactures First Commercial Scale AOS
  • BioLargo & ONM Environmental Wins Big Contracts with Municipal Clients
  • AOS Water Treatment Removes Micropollutants- peer reviewed paper confirms
  • PFAS Solution Prototype Preparing for Piloting
  • CupriDyne Technology Proven to Inactivate SARS-CoV-2
  • Iodine Solutions in the Works to Help Combat COVID-19 Crisis - BioLargo 2019 Annual Report Highlights Record Revenues, New Channel Partnerships, and Commercialization Milestones
  • BioLargo - BKT - Tomorrow Water Set to Launch JV for South East Asia
  • BioLargo Engineering Tackling PFAS Head On Ground Breaking Solution
  • PFAS Solution Found- EPA Publishes BioLargo Summary of Findings Phase I
  • BioLargo's CupriDyne Clean Proven Effective at Breaking Down Hydrogen Sulfide
  • FDA Clearance Received for BioLargo's Clyra Medical
  • BioLargo Engineering Awarded USAF Subcontracts
  • CupriDyne Clean Proven to Eliminate Odor Causing Terpenes from Cannabis- A Third Party Report
  • BioLargo's Odor & VOC Control Products for Cannabis Industry: a Pick & Shovel Play
  • BioLargo Acquires Stem Cell Therapy Technology for Medical Portfolio

BioLargo® Stock Symbol

BioLargo® Stock Symbol
Click BLGO for Stock Quote

BioLargo Press Releases

BioLargo Press Releases
Click the Bull to View

Search This Blog

Blog Archive

  • ►  2021 (34)
    • ►  June (3)
    • ►  May (7)
    • ►  April (5)
    • ►  March (8)
    • ►  February (4)
    • ►  January (7)
  • ►  2020 (66)
    • ►  December (9)
    • ►  November (3)
    • ►  October (5)
    • ►  September (2)
    • ►  August (5)
    • ►  July (8)
    • ►  June (4)
    • ►  May (8)
    • ►  April (3)
    • ►  March (9)
    • ►  February (3)
    • ►  January (7)
  • ►  2019 (61)
    • ►  December (7)
    • ►  November (6)
    • ►  October (5)
    • ►  September (9)
    • ►  August (7)
    • ►  July (6)
    • ►  June (5)
    • ►  May (4)
    • ►  April (6)
    • ►  March (3)
    • ►  February (1)
    • ►  January (2)
  • ►  2018 (62)
    • ►  December (5)
    • ►  November (8)
    • ►  October (5)
    • ►  September (5)
    • ►  August (6)
    • ►  July (6)
    • ►  June (6)
    • ►  May (8)
    • ►  April (5)
    • ►  March (5)
    • ►  February (2)
    • ►  January (1)
  • ►  2017 (43)
    • ►  December (2)
    • ►  November (5)
    • ►  October (3)
    • ►  September (6)
    • ►  August (5)
    • ►  July (3)
    • ►  June (7)
    • ►  May (3)
    • ►  April (3)
    • ►  March (2)
    • ►  February (3)
    • ►  January (1)
  • ►  2016 (36)
    • ►  December (5)
    • ►  November (1)
    • ►  October (2)
    • ►  September (5)
    • ►  August (3)
    • ►  July (2)
    • ►  June (4)
    • ►  May (5)
    • ►  April (1)
    • ►  March (2)
    • ►  February (1)
    • ►  January (5)
  • ►  2015 (28)
    • ►  December (2)
    • ►  November (5)
    • ►  October (4)
    • ►  September (1)
    • ►  August (4)
    • ►  July (2)
    • ►  May (4)
    • ►  March (2)
    • ►  February (3)
    • ►  January (1)
  • ►  2014 (14)
    • ►  December (3)
    • ►  November (2)
    • ►  October (1)
    • ►  September (3)
    • ►  August (2)
    • ►  July (1)
    • ►  May (2)
  • ►  2013 (3)
    • ►  October (2)
    • ►  June (1)
  • ►  2012 (5)
    • ►  January (5)
  • ▼  2009 (7)
    • ►  November (1)
    • ▼  July (1)
      • EPA RED for Iodine and Iodophors - Published June ...
    • ►  May (3)
    • ►  April (2)

Contributors

  • Alex Evans
  • Alex Evans
  • BioLargo
  • Tonya Chandler
  • Unknown

Forward Looking Statements

This blog, found at www.BioLargo.blogspot.com (the “Blog”), is maintained by BioLargo, Inc., a Delaware corporation (“BioLargo”, or the “Company”). This Blog features both posts written by BioLargo, and links to third party articles posted on websites with no affiliation to BioLargo (which articles may or may not be reproduced partially or in their entirety in the Blog). BioLargo makes no assurance or guaranty of the accuracy of any information posted on this Blog, or contained in articles or web postings reposted on this Blog, or linked to by this Blog. Any opinions contained in articles or posts attributed to third parties are of the third party and not of BioLargo or its management. BioLargo makes no effort to verify or correct any inaccurate information authored by third parties and posted on this Blog. Any posts of this Blog should be read in conjunction with BioLargo’s filings with the Securities and Exchange Commission, which are available to the public at www.SEC.gov, or at www.BioLargo.com.

Information in this Blog may contain forward-looking statements. With respect to any such forward-looking statements posted authored by BioLargo and not a third party, such forward-looking statements are included in accordance with the safe harbor provisions of the private securities litigation reform act of 1995, and may involve known and unknown risks, uncertainties and other factors that may cause actual results and performance in future periods to be materially different from any future results or performance suggested by the forward-looking statements. Although BioLargo’s management believes the expectations reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that actual results will not differ materially from these expectations. From time to time, these risks, uncertainties and other factors are discussed in our filings with the securities and exchange commission and can be found at www.SEC.gov.

NOTHING IN THIS BLOG OR ITS RELATED LINKS IS INTENDED TO CONSTITUTE AN OFFER TO BUY OR SELL SECURITIES.
Awesome Inc. theme. Powered by Blogger.